Abstract

We have combined saturation transfer difference NMR (STD NMR) with chemical shift imaging (CSI) and controlled concentration gradients of small molecule ligands to develop imaging STD NMR, a new tool for the assessment of protein–ligand interactions. Our methodology allows the determination of protein–ligand dissociation constants (KD) and assessment of the binding specificity in a single NMR tube, avoiding time-consuming titrations. We demonstrate the formation of suitable and reproducible concentration gradients of ligand along the vertical axis of the tube, against homogeneous protein concentration, and present a CSI pulse sequence for the acquisition of STD NMR experiments at different positions along the sample tube. Compared to the conventional methodology in which the [ligand]/[protein] ratio is increased manually, we can perform STD NMR experiments at a greater number of ratios and construct binding epitopes in a fraction (∼20%) of the experimental time. Second, imaging STD NMR also allows us to screen for non-specific binders, by monitoring any variation of the binding epitope map at increasing [ligand]/[protein] ratios. Hence, the proposed method does carry the potential to speed up and smooth out the drug discovery process.
Introduction
Investigating the nature of the molecular recognition processes between biomolecules allows us to understand how their specific interactions regulate essential processes of life. This is of paramount importance both in drug design and fundamental biological investigations. NMR is among the election techniques to carry such investigation, and saturation transfer difference NMR (STD NMR), among other ligand-based NMR techniques, stands out as a reliable and easy to apply ligand-based methodology which can provide invaluable insights into the mode of binding (binding epitope mapping) and strength of the interaction (dissociation constant, KD) of protein–ligand complexes on the weak affinity range (μM to mM).1,2
In this work, we combine STD NMR with chemical shift imaging (CSI) NMR to develop imaging STD NMR. The CSI experiments use gradient phase encoding to acquire 1D 1H STD NMR spectra at each depth, or slice, of the protein sample along a concentration gradient of the ligand in a single experiment.3 The CSI approach contrasts with the slice-selection approach in that spectra are obtained simultaneously at regular intervals along the sample, rather than from a single selected region.4 Here, each slice represents one [ligand]/[protein] ratio ([L]T/[P]T, with the T subscript indicating total molar concentration), “replacing” one sample of the traditional titration approach in which small additions of the ligand stock are manually added to the tube to gradually increase the [ligand]/[protein] ratio. The implementation of imaging STD NMR that we propose here enables us to determine dissociation constants (KD), and assess binding specificity, in a single sample tube. Unlike other published methods for the single-sample determination of KD that are based on the measurement of the line width of the ligand, our STD-based approach requires fewer assumptions about the nature of the protein–ligand complex and relaxation rates and so can be applied to a greater range of systems with confidence.5 The application of CSI NMR to a sample containing a concentration gradient has been proposed6 as a way to condense, in a single-tube, experiments traditionally requiring titrations, i.e., preparation of separate samples at variable concentrations of a given component. This approach has already been applied to determine the pKa and pKb of small molecules in aqueous and non-aqueous solvents,7 the study of weak molecular interactions through concentration gradients in agar gels,8 reaction monitoring,9 and binding affinity of macromolecules to Ca2+ and Mg2+.10
STD NMR relies on the homogeneous saturation of the receptor (generally a protein), which allows magnetization transfer to any bound ligand. For each signal, the transferred saturation, reflected by the STD factor [ηSTD, defined as (I0 – Isat)/I0], is correlated to the proximity of the given set of protons to the protein surface, which translates into the binding epitope map of the ligand in the complex.11 The ηSTD multiplied by the excess of ligand, [L]T/[P]T, is called the STD amplification factor (STD-AF) and is proportional to the concentration of the protein–ligand complex in solution. Plotting STD-AF against the ligand concentration, [L]T, we can therefore obtain binding isotherms for the complexes and hence obtain the apparent KD’s of the complexes.12,13 The saturation time, tsat, at which STD-AFs are recorded, i.e., the time for which the presaturation is applied to the protein, determines the accuracy of KD determination as the effect of ligand rebinding increases at longer saturation times.14 To avoid this effect, it is necessary to acquire STD build-up curves, recording STD-AF as a function of saturation time, at increasing [L]T/[P]T ratios, as sketched in Figure 1. KD’s can then be extracted from binding isotherms built with initial growth rates of STD-AF (STD-AF0).14 All the equations and mathematical definitions are reported in Section S2 of the Supporting Information.
Figure 1.

Sketch of the Imaging STD NMR approach for the determination of dissociation constants based on initial growth of the build-up curves. An STD-NMR build-up curve is extracted at each depth of the tube, corresponding to increasing [ligand]/[protein] ratios (bottom to top). From these, the initial slopes are calculated and plotted against the ligand concentration to obtain the binding isotherm and hence KD.
Although efficient in measuring accurate KD values, the STD NMR approach is particularly dispendious as it requires a number of manual ligand additions to the samples equal to the desired number of [L]T/[P]T ratios. Acquisition of full build-up curves after each addition also limits the number of ratios that can be assessed, if time and resources are limited or experimental conditions do not allow (for example, if the protein is particularly unstable in solution). In contrast, as summarized in Figure 1, imaging STD NMR allows us to measure dissociation constants in a single NMR sample constituted of a gradient of ligand developing along the vertical axis, against a homogeneous receptor concentration.
Additionally, using the same method, we can assess binding specificity of a given molecule to a protein target through the variation of its binding epitope with ligand concentration. The binding epitope is a map of how the STD response is distributed around the molecule, and thus which protons are closest to those of the protein.1,11 Cala and Krimm have shown that assessing the binding epitope map at increasing [ligand]/[protein] ratio is an efficient tool to discriminate between specific and non-specific binding to the protein.15 The binding epitope map of specific binders is independent of ligand concentration, while non-specific binders lose their binding epitope map information at increasing ligand concentration because of their binding all over the protein surface with multiple non-repetitive orientations, resulting in the complete loss of binding epitope information. If undetected, non-specific binders can be mistaken for promising leads and brought further in the drug discovery process, invalidating it.16 It is therefore urgent to reveal and exclude non-specific binders at an early stage. As the pool of techniques apt to spot non-specific binders is limited, we test the potential of imaging STD NMR to assess the specificity of binding, along with the measurement of KD, in a one-shot single tube experiment.
Results and Discussion
Creating Controlled Ligand Gradients
To create controlled and reproducible gradients along the vertical axis of the 5 mm NMR tube (as shown in Figure 2a), we approximate the tube to an infinite cylinder at the top of which a given amount of solute is placed and allowed to diffuse.17 The concentration, C, of the solute at each height z from the top of the tube is given by eq 1
| 1 |
where m is the total mass of solute, r is the inner radius of the NMR tube (2.1 mm), MW is the molecular weight of the solute, D is the diffusion coefficient, and t is the time elapsed since preparation of the sample. We have previously shown that a solid solute can be placed on the bottom of the tube, covered by glass beads, and a solution placed on top to create a stable and reproduceable concentration gradient by dissolution and diffusion.6,18 This approach works well for non-sticky solids like acids or salts. However, it is more challenging for sticky hydrophobic organic solids which tend to smear along the NMR tube. Furthermore, minuscule quantities of the solid would be required to determine small KD values that would be unfeasible to weigh out. Therefore, we decided to use a concentrated aqueous solution of the solute as the source for diffusion in the homogeneous protein solution.
Figure 2.

(a) Example concentration gradient produced by placing 50 μL of methyl orange solution on top of 400 μL of BSA protein in buffer. (b) Diffusion profile of tryptophan between 22 and 26 h, showing the stability of the concentration gradient needed for analysis by imaging STD NMR. Depth is the distance from the boundary, where the tryptophan solution was layered (31 mm from the tube bottom).
Protein solutions, due to their high buffer concentration, are generally denser than concentrated solutions of organic ligands. We therefore diffuse the ligand from top to bottom, carefully placing a solution of ligand on top of the protein solution, as shown in Figure 2a. In Section S11 of the Supporting Information, we also show that, should ligand solubility be a problem, heavier dimethyl sulfoxide (DMSO)-containing ligand stocks can be placed at the bottom of the tube, without affecting the development and predictability of the gradients.
| 2 |
To calculate the exact mass required to achieve the desired concentration window, we first need to determine the diffusion coefficient D. By creating a ligand gradient in the absence of protein at known diffusant volume and concentration at a given time, D can be calibrated for each ligand so that the experimental concentration 4 mm below the boundary of the ligand and protein solutions (z = 4 mm, Figure 2a) matches the prediction from eq 1. The diffusion coefficients experimentally determined for tryptophan, N-acetylglucosamine (GlcNAc), and 3-nitrophenyl-α-d-galactopyranoside (3NPG) with this approach were 5 × 10–10, 4 × 10–10, and 3 × 10–10 m2/s, respectively. These values are in good agreement with the predictions obtained using the approach presented by Evans et al.,19 which gave the values of 5.29 × 10–10, 5.09 × 10–10, and 3.83 × 10–10 m2/s, respectively, for tryptophan, GlcNAc, and 3NPG, so predictions based on the molecular weight of the ligand could be an alternative viable approach.
Once D is obtained for a ligand, we can fix the required maximum concentration at the top of the tube (for example, at 4 mm from the top of the boundary as this is the first slice that we can read), at a given time. Based on the mass obtained from eq 2, the exact volume and concentration required are calculated, aiming at volumes between 20 and 50 μL that can be easily pipetted down the wall of the tube.
An example of this approach is reported in Figure 2b, where we aimed for a maximum concentration of 3 mM tryptophan 4 mm from the top of the boundary, 22 h after preparation. Tryptophan (23 μL, 30 mM) was then layered on top of 400 μL of buffer solution, as calculated according to eq 2, and the gradient left to develop for 22 h before the spectra were acquired. The concentration of the ligand is determined by integration against the internal NMR standard, in our case pyrazine. As highlighted by the gray dotted lines, the observed value at these fixed conditions exactly matches the calculations. Importantly, this same figure shows that the gradient is stable over 4 h between 22 and 26 h. This is supported by the diffusion profile simulations reported in Figure S6 of the Supporting Information, showing how for small molecular weight ligands, concentration gradients become more stable 18 h after preparation, with 22–26 h being a suitable time for the analysis. The gradient stability enables the acquisition of build-up curves as a train of experiments at increasing saturation times, so as to ensure the accurate measurements of KD. Total experimental time depends on the number of saturation times measured and the concentration of the ligand and number of scans required, but 2 h 30 min was sufficient for the acquisition of build-up curves for the tryptophan/bovine serum albumin system, where the concentration ranged between 0.3 and 1.3 mM. The sample needs no adjustment during this period, and the required series of STD experiments can be recorded automatically. Our method thus avoids experimental complications related to the incomplete mixing or increase in volume of the sample over the course of a titration as a ligand is added.
KD Determination in a Single Tube
As model systems, we used: (i) tryptophan (W) bound to bovine serum albumin (BSA), (ii) GlcNAc bound to wheat germ agglutinin (WGA), and (iii) 3NPG as bound to cholera toxin subunit B (CTB). Ligands are shown in Figure 3. For these three complexes, the dissociation constants are reported in the literature, ranging from 200 μM (in the lower region of the affinity window detectable by STD NMR) for W/BSA, to 2 mM for the GlcNAc·WGA, while 3NPG/CTB is in the middle with a KD of about 1 mM. Additionally, W exhibits non-specific binding to BSA due to the intrinsic lipophilicity of albumins. In contrast, GlcNAc/WGA and 3NPG/CTB show very specific binding as it is often the case for carbohydrate recognizing domains.20,21
Figure 3.

Structure and atom nomenclature of the ligands in the protein–ligand complexes used as model systems in this study.
For each system, on the sample containing the ligand gradient against the homogeneous concentration of protein, we acquired a set of STD NMR build-up curves using Imaging STD NMR. This was achieved by adding pre-saturation to 1H CSI pulse sequence,3 incorporating perfect echo water suppression block to be able to analyze samples at different light water contents.
Figure 4 shows an example of the resulting spectra, and for more details, we send the reader to Sections S1 (Experimental section), S3 (imaging STD NMR control experiments and sensitivity assessment) and S9 (pulse sequence for the STD CSI experiment) of the Supporting Information. For the three systems, the binding isotherms obtained from different saturation times and from STD-AF0 are reported in Figure 5.
Figure 4.

Spectra from imaging STD NMR experiments of a sample containing a gradient of tryptophan against homogeneous concentrations of BSA. (a) 1D NMR spectrum of the sample acquired with a 30° pulse, without water suppression. (b) On- and off-resonance spectra and (c) STD difference spectra of slice 8 of 16 of the imaging STD experiment performed on the same sample. The imaging STD NMR experiment was acquired with eight scans for an experimental time of 22 min.
Figure 5.

Imaging STD NMR Langmuir binding isotherms for KD determination of the (a) tryptophan/BSA complex, based on the average of all the aromatic protons; (b) and GlcNAc/WGA, based on the methyl group signal; and (c) 3NPG/CTB complex, based on the H2,3,5 proton signal of the sugar ring. For the three complexes, we show the binding isotherms (lines) obtained from fitting either the initial slopes of build-up curves (STD-AF0), in blue dots, or from the STD-AF at increasing saturation time, in orange to brown dots. Tabulated data for the binding isotherms are reported in Section S4 of the Supporting Information, where the STD NMR build-up curves obtained at each depth of the tube, i.e., at increasing ligand concentration, and tabulated data, are also included.
KD values were extracted from all the binding isotherms, both from STD-AF initial growth rates (STD-AF0) and from STD-AF measured at individual saturation times. Excellent fits to the Langmuir equation (eq S6) were obtained in all cases (R2 > 0.99). However, in cases where high ligand excess cannot be ensured, an alternative fitting equation should be used that explicitly considers the total concentrations of protein and ligand. Both equations give equivalent results in the present work (Section S5 of the Supporting Information). In case a full STD build-up analysis cannot be carried out (e.g., limitations in protein availability and/or stability), a single saturation time titration experiment will provide an upper limit of the dissociation constant. In those cases, to get the best KD approximation, low saturation times and low protein concentrations should be used to minimize underestimation of affinity due to ligand rebinding14 (for a discussion and comparison of the KD obtained from STD-AF0 and from single saturation times, see Section S6 of the Supporting Information). The KD data obtained for the three systems from imaging STD NMR are reported in Table 1, in comparison with the conventional STD NMR titration reported in the study by Angulo et al.14 and isothermal titration calorimetry (ITC) or weak affinity chromatography (WAC) measurements reported in the literature.
Table 1. Comparison of Dissociation Constants Obtained by Imaging STD NMR, Traditional STD NMR Titration and ITC or WAC, and the Number of [L]T/[P]T Ratios Investigated and Instrument Time.
| imaging STD NMR | STD NMR titration14 | ITC or WAC | |
|---|---|---|---|
| W/BSA | |||
| KD | 231 ± 50 μM | 190 ± 20 μM | 230 ± 90 μM22 |
| number of [L]T/[P]T | 13 | 5 | |
| instrument timea | 2 h 30 min | 30 h | |
| GlcNAc/WGA Lectin | |||
| KD | 2.24 ± 0.18 mM | 2.4 ± 0.3 mM | 2.5 ± 0.15 mM20 |
| number of [L]T/[P]T | 7 | 7 | |
| instrument timea | 2 h | 21 h | |
| 3NPG/CTB | |||
| D | 0.93 ± 0.7 mM | 1.1 ± 0.1 mM23 | |
| number of [L]T/[P]T | 7 | ||
| instrument timea | 2 h 45 min | ||
Instrument time for the STD NMR titration is calculated as the sum of the instrument time required to obtain each KD in our work and as reported in ref (14), accounting for the original conditions, so as to allow direct comparison of the values obtained here and in that work.
The KD’s obtained by imaging STD NMR are comparable to those reported in the literature within the experimental uncertainties. For the W/BSA system, the uncertainty in KD is larger than the error obtained from the STD NMR titration (but smaller than error coming from ITC). This can be ascribed by the low KD (0.2 mM), requiring low concentrations, and thus higher uncertainty in the concentration of ligand determined by integration. The uncertainty associated with the KD measurement for the GlcNAc/WGA complex is smaller relative to the STD NMR titration and comparable to ITC measurements as the higher KD and ligand concentration and the presence of a strong methyl signal allow for more accurate integration.
We note that imaging STD NMR requires only 20% of the experimental time required for conventional STD NMR titrations and readily allows us to analyze up to 14 [L]T/[P]T ratios, whereas acquiring more than five points is logistically challenging with the original method, due to many factors, including protein stability over the long run. Also, for mM concentrations, our methodology may be more accurate than manual titration where the sample is repeatedly manipulated, and human factors have a larger impact. Further details on comparison between our methodology and manual STD NMR titration for KD determination are provided in Section S7 of the Supporting Information, while the effect of the protein concentration is discussed in Section S12.
Binding Specificity Assessment in a Single Tube
The second application of imaging STD NMR is the assessment of binding specificity in a single tube. It is important to remark that for this application, a new gradient sample is normally required as the concentration window required for specificity analysis is larger than that required for the KD measurements. Ideally, measurements are performed at concentrations up to at least 10× KD, to evaluate the evolution of the binding epitope mappings upon increasing the excess of ligands.
As shown in Figure 6, the two different scenarios of a specific and non-specific protein–ligand complex are sketched. For a specific binder, even large ligand excess will not affect the binding epitope as once the binding site is saturated, there is no chance for the ligand to bind anywhere else. For non-specific binders, once the binding site is saturated, the ligand can bind everywhere else on the protein surface, resulting in loss of binding epitope mapping information. Below the sketches, the experimental normalized binding epitope mappings at increasing ligand concentration are reported for GlcNAc/WGA and 3NPG/CTB, and W/BSA. It is evident, from the comparison of the two histograms, that GlcNAc and 3NPG exhibit specific binding to the WGA lectin and CTB-binding domain (Figure 6a) as the binding epitope remains constant at increasing ligand concentration. Once the binding site is saturated, the excess ligand stays free in solution without any non-specific interaction with the protein surface. On the contrary, for the W/BSA complex, we can initially see a binding epitope pattern with Hζ2 and Hζ3 receiving higher saturation relative to Hε, η2, and δ.
Figure 6.

Assessment of binding specificity by imaging STD NMR. Top: cartoons of how STD NMR binding epitopes can be used for assessing the specificity of binding, where a specific protein–ligand complex is represented in (a), and a non-specific protein–ligand complex is represented in (b). Bottom: histograms of the binding epitope mapping of the complexes GlcNAc/WGA (top) and W/BSA (bottom) obtained from initial slopes derived from imaging STD NMR build-up curves at increasing ligand concentration, from a single tube. For the atom nomenclature, see Figure 3. GlcNAc-binding epitopes are normalized to the methyl group which gave the strongest STD response. The strongest STD response exhibited by the tryptophan changed for each concentration due to non-specific binding. Tabulated data are reported in Section S8.
This epitope pattern is completely lost when the ligand concentration goes above 1–2 mM as once the binding site is saturated, tryptophan starts interacting in a non-specific manner with the (very lipophilic) BSA protein surface (Figure 6b). While Cala and Krimm propose the study of the binding epitope at two different [ligand]/[protein] ratios to test for specificity,15 our imaging STD NMR experiment is potentially more reliable due to the higher number of ratios investigated.
Conclusions
We have hereby developed imaging STD NMR, by combining CSI NMR and STD NMR, to obtain spatially resolved STD NMR experiments along the z-axis of an NMR tube and apply it to samples containing ligand gradients against a homogeneous protein concentration. We have implemented this methodology into two distinguished applications, the first allowing us to determine dissociation constants in a single NMR tube and the second allowing us to assess the specificity of binding. We consider the application of imaging STD NMR to assess the specificity of binding an important implementation as detecting non-specific binder is a challenging task, and a limited number of methodologies are available to the scope.
Finally, we envision an even wider applicability of imaging STD NMR, going beyond the KD determination and specificity of binding assessment. This could range from the study of protein–ligand interactions in the presence of gradients of competitors, as well as at variable pH values, and various co-solvent concentrations to identify optimal conditions for binding. Furthermore, beyond the realm of protein–ligand complexes, the same qualitative approach could be used to structurally characterize key molecular interactions in a broad range of systems such as polymer emulsions,24,25 micellar pharmaceutics,26 and DNA-based molecular machines, at variable conditions in a single tube.
Acknowledgments
This work is dedicated to the memory of Dr. Karol Nartowski. We are grateful for the use of the University of East Anglia Faculty of Science NMR facility. We thank Mestrelab Research S.L. for technical advice and the gift of a software license for Mnova 14.3.1.
Glossary
Abbreviations
- STD NMR
saturation transfer difference NMR
- CSI
chemical shift imaging
- STD-AF
STD amplification factor
- W
tryptophan
- BSA
bovine serum albumin
- GlcNAc
N-acetylglucosamine
- WGA
wheat germ agglutinin
- 3NPG
3-nitrophenyl-α-d-galactopyranoside
- CTB
cholera toxin subunit B
- ITC
isothermal titration calorimetry
- WAC
weak affinity chromatography
Data Availability Statement
Research data will be available at: https://people.uea.ac.uk/en/datasets/.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacs.3c02218.
Experimental section; mathematical derivation of STD-AF0 and of KD from the STD-AF0-binding isotherm; imaging STD NMR control experiments and comparison of STD NMR and imaging NMR spectra; build-up curves with data and binding isotherms data for the three complexes; mathematical derivation of more general fitting for KD determination; KD values at single saturation times; comparison for instrument time for STD NMR titration and imaging STD NMR; binding epitope mappings at increasing concentrations for W/BSA and GlcNAc/WGA; pulse sequence for the STD CSI experiment (Bruker); amount of mass and concentration for gradient formation of small molecules; effect of DMSO in the stock of the diffusion profile; effect of the protein concentration on sensitivity and simulation of protein diffusion; macros for automated imaging STD NMR data processing (Bruker); STD NMR data processing: manual method and automation; and STD NMR data processing on Mnova 14.3.1 by line fitting (PDF)
Calculation of mass and concentration of ligands and for imaging STD NMR data processing (XLSX)
Author Contributions
All authors have given approval to the final version of the manuscript.
M.W. and S.M. thank UKRI for funding via a Future Leaders Fellowship to M.W. (MR/T044020/1). J.A. thanks the Ministerio de Ciencia e Innovación (grant PID2019-109395GB-I00) and the Junta de Andalucia (Proyectos I + D + I, grant PY20_01176).
The authors declare no competing financial interest.
Supplementary Material
References
- Mayer M.; Meyer B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 2001, 123, 6108–6117. 10.1021/ja0100120. [DOI] [PubMed] [Google Scholar]
- Mayer M.; Meyer B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem., Int. Ed. 1999, 38, 1784–1788. . [DOI] [PubMed] [Google Scholar]
- Mouriño P. T.; Merle C.; Koos M. R. M.; Luy B.; Gil R. R. Probing spatial distribution of alignment by deuterium NMR imaging. Chem.—Eur. J. 2013, 19, 7013–7019. 10.1002/chem.201300254. [DOI] [PubMed] [Google Scholar]
- Nepravishta R.; Monaco S.; Muñoz-García J. C.; Khimyak Y. Z.; Angulo J. Spatially resolved STD-NMR applied to the study of solute transport in biphasic systems: application to protein-ligand interactions. Nat. Prod. Commun. 2019, 14, 1934578X1984978. 10.1177/1934578x19849789. [DOI] [Google Scholar]
- Shortridge M. D.; Hage D. S.; Harbison G. S.; Powers R. Estimating protein– ligand binding affinity using high-throughput screening by NMR. J. Comb. Chem. 2008, 10, 948–958. 10.1021/cc800122m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallace M.; Adams D. J.; Iggo J. A. Titrations without the Additions: The Efficient Determination of p K a Values Using NMR Imaging Techniques. Anal. Chem. 2018, 90, 4160–4166. 10.1021/acs.analchem.8b00181. [DOI] [PubMed] [Google Scholar]
- Schenck G.; Baj K.; Iggo J. A.; Wallace M. Efficient p K a Determination in a Nonaqueous Solvent Using Chemical Shift Imaging. Anal. Chem. 2022, 94, 8115–8119. 10.1021/acs.analchem.2c00200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mitrev Y.; Simova S.; Jeannerat D. NMR analysis of weak molecular interactions using slice-selective experiments via study of concentration gradients in agar gels. Chem. Commun. 2016, 52, 5418–5420. 10.1039/c6cc01853j. [DOI] [PubMed] [Google Scholar]
- Niklas T.; Stalke D.; John M. Single-shot titrations and reaction monitoring by slice-selective NMR spectroscopy. Chem. Commun. 2015, 51, 1275–1277. 10.1039/c4cc08329f. [DOI] [PubMed] [Google Scholar]
- Wallace M.; Holroyd J.; Kuraite A.; Hussain H. Does it bind? A method to determine the affinity of calcium and magnesium ions for polymers using 1H NMR spectroscopy. Anal. Chem. 2022, 94, 10976–10983. 10.1021/acs.analchem.2c01166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Angulo J.; Nieto P. M. STD-NMR: application to transient interactions between biomolecules—a quantitative approach. Eur. Biophys. J. 2011, 40, 1357–1369. 10.1007/s00249-011-0749-5. [DOI] [PubMed] [Google Scholar]
- Pickhardt M.; Larbig G.; Khlistunova I.; Coksezen A.; Meyer B.; Mandelkow E. M.; Schmidt B.; Mandelkow E. Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of τ aggregation and toxicity in vitro and in cells. Biochemistry 2007, 46, 10016–10023. 10.1021/bi700878g. [DOI] [PubMed] [Google Scholar]
- Neffe A. T.; Bilang M.; Grüneberg I.; Meyer B. Rational optimization of the binding affinity of CD4 targeting peptidomimetics with potential anti HIV activity. J. Med. Chem. 2007, 50, 3482–3488. 10.1021/jm070206b. [DOI] [PubMed] [Google Scholar]
- Angulo J.; Enríquez-Navas P. M.; Nieto P. M. Ligand–receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates. Chem.—Eur. J. 2010, 16, 7803–7812. 10.1002/chem.200903528. [DOI] [PubMed] [Google Scholar]
- Cala O.; Krimm I. Ligand-orientation based fragment selection in STD NMR screening. J. Med. Chem. 2015, 58, 8739–8742. 10.1021/acs.jmedchem.5b01114. [DOI] [PubMed] [Google Scholar]
- Bisson J.; McAlpine J. B.; Friesen J. B.; Chen S. N.; Graham J.; Pauli G. F. Can invalid bioactives undermine natural product-based drug discovery?. J. Med. Chem. 2016, 59, 1671–1690. 10.1021/acs.jmedchem.5b01009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crank J.The Mathematics of Diffusion; Oxford University Press, 1979, p 414. [Google Scholar]
- Wallace M.; Lam K.; Kuraite A.; Khimyak Y. Z. Rapid determination of the acidity, alkalinity and carboxyl content of aqueous samples by 1H NMR with minimal sample quantity. Anal. Chem. 2020, 92, 12789–12794. 10.1021/acs.analchem.0c02594. [DOI] [PubMed] [Google Scholar]
- Evans R.; Dal Poggetto G.; Nilsson M.; Morris G. A. Improving the interpretation of small molecule diffusion coefficients. Anal. Chem. 2018, 90, 3987–3994. 10.1021/acs.analchem.7b05032. [DOI] [PubMed] [Google Scholar]
- Bains G.; Lee R. T.; Lee Y. C.; Freire E. Microcalorimetric study of wheat germ agglutinin binding to N-acetylglucosamine and its oligomers. Biochemistry 1992, 31, 12624–12628. 10.1021/bi00165a012. [DOI] [PubMed] [Google Scholar]
- Fernández-Alonso M. d. C.; Diaz D.; Alvaro Berbis M.; Marcelo F.; Canada J.; Jimenez-Barbero J. Protein-carbohydrate interactions studied by NMR: from molecular recognition to drug design. Curr. Protein Pept. Sci. 2012, 13, 816–830. 10.2174/138920312804871175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fielding L.; Rutherford S.; Fletcher D. Determination of protein–ligand binding affinity by NMR: observations from serum albumin model systems. Magn. Reson. Chem. 2005, 43, 463–470. 10.1002/mrc.1574. [DOI] [PubMed] [Google Scholar]
- Bergström M.; Liu S.; Kiick K. L.; Ohlson S. Cholera Toxin Inhibitors Studied with High-Performance Liquid Affinity Chromatography: A Robust Method to Evaluate Receptor–Ligand Interactions. Chem. Biol. Drug Des. 2009, 73, 132–141. 10.1111/j.1747-0285.2008.00758.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gouilleux B.; Moussallieh F. M.; Lesot P. Anisotropic 1H STD-NMR Spectroscopy: Exploration of Enantiomer-Polypeptide Interactions in Chiral Oriented Environments. ChemPhysChem 2023, 24, e202200508 10.1002/cphc.202300040. [DOI] [PubMed] [Google Scholar]
- Watchorn J.; Stuart S.; Burns D. C.; Gu F. X. Mechanistic Influence of Polymer Species, Molecular Weight, and Functionalization on Mucin–Polymer Binding Interactions. ACS Appl. Polym. Mater. 2022, 4, 7537–7546. 10.1021/acsapm.2c01220. [DOI] [Google Scholar]
- Malec K.; Monaco S.; Delso I.; Nestorowicz J.; Kozakiewicz-Latała M.; Karolewicz B.; Khimyak Y. Z.; Angulo J.; Nartowski K. P. Unravelling the mechanisms of drugs partitioning phenomena in micellar systems via NMR spectroscopy. J. Colloid Interface Sci. 2023, 638, 135–148. 10.1016/j.jcis.2023.01.063. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Research data will be available at: https://people.uea.ac.uk/en/datasets/.
